Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), has announced employment inducement awards for its new President and CEO, Anshul Thakral, effective August 4, 2025.
The compensation package includes 1,250,000 performance share units (PSUs) that vest after three years subject to performance goals, and 1,250,000 restricted stock units (RSUs) that vest in three equal annual installments. Both awards are contingent on continuous employment or earlier vesting due to change of control and certain termination events.
The grants were approved by independent board members under the Company's 2025 Inducement Award Plan, complying with Nasdaq Listing Rule 5635(c)(4).
Fortrea (Nasdaq: FTRE), un'importante organizzazione globale di ricerca a contratto (CRO), ha annunciato premi di incentivazione all'assunzione per il suo nuovo Presidente e CEO, Anshul Thakral, con effetto dal 4 agosto 2025.
Il pacchetto retributivo comprende 1.250.000 unit脿 azionarie a prestazione (PSU) che maturano dopo tre anni al raggiungimento di specifici obiettivi di performance, e 1.250.000 unit脿 azionarie vincolate (RSU) che maturano in tre rate annuali uguali. Entrambi i premi sono subordinati alla continuit脿 lavorativa o a una maturazione anticipata in caso di cambio di controllo o di determinati eventi di risoluzione del rapporto.
Le assegnazioni sono state approvate dai membri indipendenti del consiglio nell鈥檃mbito del Piano di Premi di Incentivazione 2025 della Societ脿, in conformit脿 con la Regola Nasdaq 5635(c)(4).
Fortrea (Nasdaq: FTRE), una destacada organizaci贸n global de investigaci贸n por contrato (CRO), ha anunciado premios por inducci贸n laboral para su nuevo Presidente y CEO, Anshul Thakral, con efecto a partir del 4 de agosto de 2025.
El paquete de compensaci贸n incluye 1.250.000 unidades de acciones con desempe帽o (PSUs) que se consolidan tras tres a帽os sujetos a objetivos de rendimiento, y 1.250.000 unidades de acciones restringidas (RSUs) que se consolidan en tres cuotas anuales iguales. Ambos premios est谩n condicionados a la continuidad laboral o a una consolidaci贸n anticipada debido a un cambio de control y ciertos eventos de terminaci贸n.
Las concesiones fueron aprobadas por miembros independientes de la junta bajo el Plan de Premios por Inducci贸n 2025 de la Compa帽铆a, cumpliendo con la Regla de Cotizaci贸n Nasdaq 5635(c)(4).
Fortrea (雮橃姢雼�: FTRE)電� 旮�搿滊矊 靹犽弰 瓿勳暯 鞐瓣惮 旮瓣磤(CRO)鞙茧靹�, 2025雲� 8鞗� 4鞚茧秬搿� 靸� 須岇灔 瓴� CEO鞚� Anshul Thakral鞐愱矊 瓿犾毄 鞙犾澑 氤挫儊鞚� 氚滍憸頄堨姷雼堧嫟.
氤挫儊 韺偆歆�鞐愲姅 靹标臣 氇╉憸 雼劚 鞁� 3雲� 頉勳棎 氩犾姢韺呺悩電� 1,250,000臧滌潣 靹标臣 欤检嫕 雼渼(PSU)鞕� 3雲勳棎 瓯胳硱 毵る厔 霃欖澕頃橁矊 氩犾姢韺呺悩電� 1,250,000臧滌潣 鞝滍暅 欤检嫕 雼渼(RSU)臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. 霊� 氤挫儊 氇憪 歆�靻嶌爜鞚� 瓿犾毄 靸來儨 霕愲姅 歆�氚瓣秾 氤�瓴� 氚� 韸轨爼 頃搓碃 靷湢搿� 鞚疙暅 臁瓣赴 氩犾姢韺� 臁瓣贝鞚� 鞛堨姷雼堧嫟.
鞚� 氤挫儊鞚� 須岇偓鞚� 2025雲� 鞙犾澑 氤挫儊 瓿勴殟鞐� 霐半澕 霃呺 鞚挫偓霌れ潣 鞀轨澑鞚� 氚涭晿鞙茧┌, 雮橃姢雼� 靸侅灔 攴滌箼 5635(c)(4)毳� 欷�靾橅暕雼堧嫟.
Fortrea (Nasdaq : FTRE), un organisme mondial de recherche sous contrat (CRO) de premier plan, a annonc茅 des r茅compenses d'incitation 脿 l'emploi pour son nouveau pr茅sident et directeur g茅n茅ral, Anshul Thakral, 脿 compter du 4 ao没t 2025.
Le package de r茅mun茅ration comprend 1 250 000 unit茅s d'actions de performance (PSU) qui seront acquises apr猫s trois ans sous r茅serve d'objectifs de performance, ainsi que 1 250 000 unit茅s d'actions restreintes (RSU) acquises en trois versements annuels 茅gaux. Les deux r茅compenses sont conditionn茅es 脿 une continuit茅 d'emploi ou 脿 une acquisition anticip茅e en cas de changement de contr么le et de certains 茅v茅nements de cessation.
Ces attributions ont 茅t茅 approuv茅es par les administrateurs ind茅pendants dans le cadre du plan d'incitation 2025 de la soci茅t茅, conform茅ment 脿 la r猫gle Nasdaq 5635(c)(4).
Fortrea (Nasdaq: FTRE), ein f眉hrendes globales Vertragsforschungsunternehmen (CRO), hat Anreizverg眉tungen f眉r seine neue Pr盲sidentin und CEO, Anshul Thakral, mit Wirkung zum 4. August 2025 bekannt gegeben.
Das Verg眉tungspaket umfasst 1.250.000 Performance-Aktieneinheiten (PSUs), die nach drei Jahren unter Erf眉llung von Leistungszielen vesten, sowie 1.250.000 Restricted Stock Units (RSUs), die in drei gleichen j盲hrlichen Raten vesten. Beide Zuteilungen sind an eine ununterbrochene Anstellung gebunden oder k枚nnen bei Kontrollwechsel und bestimmten K眉ndigungsereignissen vorzeitig vesten.
Die Zuteilungen wurden von unabh盲ngigen Vorstandsmitgliedern im Rahmen des Inducement Award Plans 2025 des Unternehmens genehmigt und entsprechen der Nasdaq-Listing-Regel 5635(c)(4).
- Appointment of new President and CEO
- Significant equity-based compensation package aligns executive interests with shareholders
- Potential dilution from 2.5 million new shares
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the 鈥淐ompany鈥�), a leading global contract research organization (CRO), today announced that it issued grants of employment inducement awards to Anshul Thakral, the Company鈥檚 recently appointed President and Chief Executive Officer, as an inducement material to Mr. Thakral becoming a new employee of the Company. The grants were previously approved by the independent members of the Company鈥檚 Board of Directors and were made in connection with Mr. Thakral鈥檚 start date with the Company on August 4, 2025 (the 鈥淓ffective Date鈥�).
The awards consisted of (i) 1,250,000 performance share units (鈥淧SUs鈥�) that will vest, if at all, at the end of a three-year vesting period subject to certain performance goals and (ii) 1,250,000 restricted stock units (鈥淩SUs鈥�) that vest in three equal annual installments from the Effective Date. In each case, vesting of the PSUs and RSUs is subject to Mr. Thakral鈥檚 continuous employment through the applicable vesting date or earlier vesting due to a change of control and certain termination events.
The PSUs and RSUs were granted under the Company鈥檚 2025 Inducement Award Plan to Mr. Thakral, who was not previously employed by the Company, as an inducement material to Mr. Thakral鈥檚 employment with the Company, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea鈥檚 solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at and follow us on and (formerly Twitter).
Fortrea Contacts
Hima Inguva (Investors) 鈥� 877-495-0816, [email protected]
Sue Zaranek (Media) 鈥� 919-943-5422, [email protected]
Kate Dillon (Media) 鈥� 646-818-9115, [email protected]
FAQ
What compensation package did Fortrea (FTRE) offer to its new CEO?
When does Anshul Thakral start as Fortrea's new CEO?
What are the vesting conditions for Fortrea's CEO stock awards?
Why did Fortrea issue these inducement awards?
